CN103290039A - Alpha-amylase derived from animal feces metagenome and gene of the alpha-amylase - Google Patents

Alpha-amylase derived from animal feces metagenome and gene of the alpha-amylase Download PDF

Info

Publication number
CN103290039A
CN103290039A CN201310249147XA CN201310249147A CN103290039A CN 103290039 A CN103290039 A CN 103290039A CN 201310249147X A CN201310249147X A CN 201310249147XA CN 201310249147 A CN201310249147 A CN 201310249147A CN 103290039 A CN103290039 A CN 103290039A
Authority
CN
China
Prior art keywords
alpha
amylase
gene
gly
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310249147XA
Other languages
Chinese (zh)
Other versions
CN103290039B (en
Inventor
许波
黄遵锡
杨富亚
李俊俊
唐湘华
周峻沛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yunnan Normal University
Original Assignee
Yunnan Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yunnan Normal University filed Critical Yunnan Normal University
Priority to CN201310249147.XA priority Critical patent/CN103290039B/en
Publication of CN103290039A publication Critical patent/CN103290039A/en
Application granted granted Critical
Publication of CN103290039B publication Critical patent/CN103290039B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention relates to alpha-amylase derived from animal feces metagenome and a gene of the alpha-amylase. The alpha-amylase gene is 1458 bp in length and the sequence of the alpha-amylase gene is shown as SEQIDNO.1. The gene encodes 485 amino acids and the sequence of the amino acids is shown as SEQIDNO.2. The alpha-amylase provided by the invention has characters that the optimal operative pH is 5.6; the enzyme activity remains larger than 65% when the pH is ranging from 4.6 to 6.6; the enzyme activity remains larger than 70% after the alpha-amylase is treated at a pH ranging from 4.0 to 8.0 for 1 h; the optimal operative temperature is 50 DEG C; and the alpha-amylase is relatively stable at 37 DEG C, and the enzyme activity remains larger than 80% after the enzyme is kept at 37 DEG C for 50 min. As a novel enzyme preparation, the alpha-amylase provided by the invention can be widely used in forage processing industry, starch processing industry, and the like.

Description

A kind of from the grand genomic α-Dian Fenmei of animal excrement and gene thereof
Technical field
The invention belongs to microorganism and gene engineering technology field, be specifically related to a kind of from the grand genomic α-Dian Fenmei of animal excrement and gene thereof.
Background technology
α-Dian Fenmei (EC 3.2.1.1) is a kind of inscribe glucuroide, α-1 in the energy hydrolyzed starch, the 4-glucoside bond, generate short chain dextrin different in size and a spot of low molecule carbohydrate, thereby the viscosity of starch paste is descended rapidly, namely play the effect that reduces denseness and " liquefaction ", so be called Ye Huamei again.α-Dian Fenmei extensively is present in the various biologies such as people, animal, plant, fungi and bacterium, reported first was separated α-Dian Fenmei so far in 1956, the various countries investigator has separated and has identified and surpassed 120 kinds of α-Dian Fenmei, wherein mainly be the bacillus that derives from microorganism ( Bacillus), Aspergillus ( Aspergillus), streptomyces ( Streptomyces) and yeast.
Because the animal ingestion kind is plant and animal food widely, make the microorganism that exists in its gi tract possess corresponding special physiological, metabolic characteristic, can produce various enzymes to decompose the materials such as starch, pectin, Mierocrystalline cellulose, protein and fat in the food.Therefore, the animal gastrointestinal tract microorganism itself is huge, a undeveloped enzyme genetic resources storehouse, is containing a large amount of potential enzyme genetic resourceses.
Yet, traditional microorganism pure culture technigne makes that accounting for microbe species can not culturing micro-organisms can't separate acquisition more than 99%, therefore especially the anaerobion cultivation property in the enteron aisle is lower, and the traditional method of screening novel enzyme by the separation and Culture microorganism has limited popularity and the validity of screening greatly.Grand genomics has been avoided the problem of microorganism separation and Culture, has greatly expanded the space that utilizes of Microbial resources, for seeking and finding that new functional gene and biological catalyst---enzyme provides new research strategy.At present, the investigator has utilized grand genome-based technologies successfully to screen a plurality of amylases genes, but research field mainly concentrates on water body and soil (Delavat et al. Sci Rep.2012,2:354; Liu et al. Mar Biotechnol (NY) .2012,14 (3): 253-260; Sharma et al. Appl Microbiol Biotechnol. 2010,86 (6): 1821-1828), be research less (Tasse et al. Genome Res. 2010, the 20:1605-1612 that object carries out with the animal gastrointestinal tract microorganism; Ferrer et al. Biotechnol J. 2007,2:207-213).
Summary of the invention
The purpose of this invention is to provide a kind of new for the grand genomic α-Dian Fenmei of animal excrement.
A further object of the present invention provides the gene of the above-mentioned α-Dian Fenmei of coding.
Another object of the present invention provides the recombinant expression vector that comprises said gene.
Another object of the present invention provides the recombinant bacterial strain with described recombinant expression vector transformed host cell gained.
Of the present invention a kind of from the grand genomic alpha-amylase gene of animal excrement, its nucleotide sequence is shown in SEQ ID NO.1, and the size of this gene is 1458bp.
A kind of α-Dian Fenmei of the present invention, its aminoacid sequence shown in SEQ ID NO.2, totally 485 amino acid, its theoretical molecular is 55.439 kDa.
The suitableeest action pH of α-Dian Fenmei of the present invention is 5.6, can keep 65% above enzyme to live between pH 4.6-6.6; Handle 1h in pH 4.0-8.0 scope after, enzyme is lived residue more than 70%; Optimum temperature is 50 ℃, and is comparatively stable under 37 ℃ of conditions, and tolerance 50min still keeps the enzyme more than 80% to live.
The present invention at first extracts the preparation microbe genome DNA from the ight soil of Japan honeybee monkey, made up grand genomic library with this DNA, fosmid carrier pCC1FOS and intestinal bacteria then, by the functional screening method, screening obtains can form transparent circle and the higher strains A my4-7-2 of amylase activity on starch-containing substrate flat board from the library.Extract the fosmid plasmid from strains A my4-7-2, transformed into escherichia coli has made up the subclone library with being connected also with carrier PUC118 behind this fosmid plasmid fragmentation then, obtains to form the strains A myC-1-5 of transparent circle from the library by functional screening.From strains A myC-1-5, extract plasmid, with this plasmid encoding gene of α-Dian Fenmei that has been the template method separating clone that passes through PCR PlA.With this alpha-amylase gene PlA is connected with plasmid pEASY-E1 and obtains recombinant expression vector, then transformed into escherichia coli BL21(DE3) obtain recombinant bacterial strain.Through the BLAST of NCBI website comparison, derive from human gi-tract among this alpha-amylase gene amino acid sequence coded and the GenBank Bifidobacterium pseudocatenulatumImaginary albumen have the highest consistence (70%).
The method for preparing α-Dian Fenmei of the present invention is carried out according to the following steps:
1) cultivates above-mentioned recombinant bacterial strain, induce recombinant alpha-amylases to express;
2) reclaim the also expressed α-Dian Fenmei of purifying.
α-Dian Fenmei of the present invention has following character: the suitableeest action pH is 5.6, can keep 65% above enzyme to live between pH 4.6-6.6; Handle 1h in pH 4.0-8.0 scope after, enzyme is lived residue more than 70%; Optimum temperature is 50 ℃, and is comparatively stable under 37 ℃ of conditions, and tolerance 50min still keeps the enzyme more than 80% to live.Above character shows α-Dian Fenmei of the present invention as a kind of novel enzyme preparation, can be widely used in feed, starch processing industry etc.
Description of drawings
Fig. 1: the SDS-PAGE in the recombinant alpha-amylases of expression in escherichia coli analyzes, wherein, and M: low molecular weight protein Marker; The recombinant alpha-amylases of purifying under 1~4:NTA-300, NTA-200, NTA-100 and the NTA-80 elution requirement; 5: the intestinal bacteria culture supernatant that contains the recombinant alpha-amylases gene.
Fig. 2: the optimal pH of recombinant alpha-amylases.
Fig. 3: the pH stability of recombinant alpha-amylases.
Fig. 4: the optimum temperuture of recombinant alpha-amylases.
Fig. 5: the thermostability of recombinant alpha-amylases.
Embodiment
Test materials and reagent
1, bacterial strain and carrier: bacterial strain Escherichia coliEPI300 and carrier pCC1FOS purchase the company in EPICENTRE, subcloning vector PUC118 and host E. coliDH10B purchases the company in TaKaRa, E.coliBL21(DE3) purchase the company in Novagen, coli expression carrier pEASY-E1 purchases in the Beijing Quanshijin Biotechnology Co., Ltd.
2, genetically engineered operation enzyme, test kit and other biochemical reagents: restriction enzyme, archaeal dna polymerase, ligase enzyme and dNTP, Blunting Kination Ligation(BKL) Kit is available from TaKaRa company; Other all is domestic reagent (all can buy from common biochemical reagents company and obtain).
3, substratum:
TB substratum: A component: Tryptones 12g, yeast powder 24g, glycerine 4mL, agar 2% is dissolved in the 900mL distilled water; B component (PBS damping fluid): KH 2PO 49.5g and KH 2PO 43H 2O 82.16g is dissolved in the 100mL distilled water; A, B component respectively at 120 ℃ of sterilization 30min after, to be cooledly both are mixed during to 65 ℃ of left and right sides.Solid medium adds 2.0%(w/v on this basis) agar.
The LB substratum: Peptone 10g, Yeast extract 5g, NaCl 10g, adding distil water are to 1000mL, and pH is (being about 7) naturally.Solid medium adds 2.0%(w/v on this basis) agar.
Illustrate: make the experimental methods of molecular biology specify in following examples, all carry out with reference to listed concrete grammar in " molecular cloning experiment guide " (third edition) J. Sa nurse Brooker one book, perhaps carry out according to test kit and product description.
Embodiment one: the acquisition of alpha-amylase gene
1, the grand genomic library construction of Japan honeybee monkey fecal microorganism
(extracting method can be with reference to patent " a kind of genomic method of high molecular of extracting from animal excrement " to extract microbe genome DNA from Japan's honeybee monkey ight soil, publication number 102586234A), fragmentation is by the dna fragmentation that pulsed field gel electrophoresis separates, agarose gel electrophoresis reclaims the about 40kb of size, and the dna fragmentation of recovery is connected with fosmid carrier pCC1FOS and transfecting host bacterium E.coliEPI300 coats on the LB flat board that contains 12.5 μ g/mL paraxin, and 37 ℃ of overnight incubation obtain transformant, this clone library are stored in 96 orifice plates ,-80 ℃ of preservations.
2, produce the functional screening of amylase positive colony
The clone bacterium liquid of preserving in 96 orifice plates is suitably diluted, and it is dull and stereotyped to coat TB-paraxin (the 12.5 μ g/mL) screening that contains 0.1% Zulkovsky starch, uses 0.5% iodine staining behind 37 ℃ of cultivation 48h, selects and can form transparent circle and the higher bacterial strain of amylase activity.
3, subclone library construction and screening
Screening obtains to form transparent circle and the higher strains A my4-7-2 of amylase activity from above-mentioned grand genomic library, therefrom extracts fosmid plasmid and fragmentation.Plasmid DNA employing Blunting Kination Ligation(BKL behind the fragmentation) Kit carries out flush endization and 5 ' terminal phosphate processing, agarose gel electrophoresis detects also to be cut glue and reclaims dna fragmentation in 2.0~4.0kb scope, then the DNA that reclaims is connected with carrier PUC118 and transforms E. coliDH10B has made up the subclone library.Library bacterium liquid is suitably coated LB-penbritin (100 μ g/mL) the screening flat board that contains 0.1% Zulkovsky starch after the dilution, uses 0.5% iodine staining behind 37 ℃ of cultivation 48h, selects and can form transparent circle and the higher bacterial strain of amylase activity.
4, the clone of alpha-amylase gene
Screening obtains to form the strains A myC-1-5 of transparent circle from above-mentioned subclone library, therefrom extracts plasmid and checks order.According to sequencing result, the insertion fragment total length 2541bp of this plasmid utilizes ORF finder on-line analysis to obtain a length and is the complete open reading frame (ORF) of 1539bp, through the no matching sequence of BLAST comparison.Utilize SignalP 4.1 on-line prediction signal peptides, the 1st~27 amino acid of its N end has typical signal peptide feature.According to The sequencing results design amplification alpha-amylase gene ( PlA) primer of mature peptide:
plA F:5`-GCGACCAATCGCGACAGCTACG-3`
plA R:5`-CTAGAGTCTCACATAGGCCACC-3`
Be template with the plasmid that extracts among the strains A myC-1-5, with the encoding gene of above-mentioned primer by the pcr amplification α-Dian Fenmei PlA.
Embodiment two: the preparation of recombinant alpha-amylases
With this alpha-amylase gene PlA is connected with plasmid pEASY-E1 and obtains recombinant expression vector, then transformed into escherichia coli BL21(DE3) obtain recombinant bacterial strain.Get and contain recombinant expression vector E. coliBL21(DE3) bacterial strain, the inoculum size with 0.1% are inoculated in LB(and contain 100 μ g/mL Amp) in the nutrient solution, 37 ℃ of quick oscillation 16h.Then the bacterium liquid of this activation being inoculated into fresh LB(with 1% inoculum size and containing 100 μ g/mL Amp) in the nutrient solution, quick oscillation is cultivated about 2 – 3h(OD 600Reach 0.6 – 1.0) after, the alpha-lactose that adds final concentration 0.5% is induced, and continues the about 20h of shaking culture or 26 ℃ of about 8h of shaking culture in 20 ℃.The centrifugal 5min of 12000rpm collects thalline.Behind an amount of pH7.0 Tris-HCl damping fluid suspension thalline, ultrasonic disruption thalline under the low temperature water-bath., behind the centrifugal 10min of 13,000rpm, draw supernatant and use Nickel-NTA Agarose purifying target protein with first enzyme liquid concentrated in the upper eye lid.SDS-PAGE result (Fig. 1) shows that recombinant alpha-amylases has obtained expression in intestinal bacteria, is single band behind purifying under the NTA-300 elution requirement.
The activation analysis of recombinant alpha-amylases:
Activity determination method adopts 3,5-dinitrosalicylic acid (DNS) method: Zulkovsky starch is dissolved in the 0.1M damping fluid, and it is 0.2%(w/v that preparation obtains final concentration) substrate solution; Get 900 μ L substrate solution preheating 5min under temperature of reaction, add 100 μ L enzyme liquid, accurately react 5min, add 1.5mL DNS termination reaction then, boiling water boils 5min, is cooled to and measures the OD value after the room temperature under the 540nm wavelength.1 enzyme unit alive (U) is defined as the required enzyme amount of per minute bottom exploded deposits yields 1 μ mol reducing sugar under given condition.
The property testing of recombinant alpha-amylases:
1, the measuring method of the optimal pH of recombinant alpha-amylases and pH stability is as follows:
The optimal pH of enzyme is measured: the recombinant alpha-amylases of embodiment two purifying is carried out enzymatic reaction under the damping fluid of 50 ℃ and pH3.0 – 8.0.The pH of enzyme stability is measured: the enzyme liquid of purifying is placed the 0.1M damping fluid of pH2.0 – 11.0, and room temperature is placed 1h, carries out enzymatic reaction then under pH5.6 and 50 ℃, with untreated enzyme liquid in contrast.Damping fluid is: 0.1M citric acid-Sodium phosphate dibasic damping fluid (pH2.0 – 8.0), 0.1M Tris-HCl(pH8.0 – 9.0) and 0.1M glycine-NaOH damping fluid (pH9.0 – 11.0).Be substrate with the Zulkovsky starch, reaction 5min measures the zymologic property of the recombinant alpha-amylases of purifying.The result shows: the optimal pH of recombinant alpha-amylases is 5.6, can keep 65% above enzyme (Fig. 2) alive between pH 4.6-6.6; Handle 1h in pH 4.0-8.0 scope after, enzyme is lived residue more than 70% (Fig. 3).
2, the optimum temperuture of recombinant alpha-amylases and thermal stability determination method are as follows:
The optimum temperuture of enzyme is measured: in the damping fluid of pH5.6, carry out enzymatic reaction under 80 ℃ of 0 –.The thermal stability determination of enzyme: after placing the temperature (37 ℃, 50 ℃ or 60 ℃) of setting to handle 0 – 50min the enzyme liquid of same enzyme amount, under pH5.6 and 50 ℃, carry out enzymatic reaction, with untreated enzyme liquid in contrast.Be substrate with the Zulkovsky starch, reaction 5min measures the zymologic property of the recombinant alpha-amylases of purifying.The result shows: the optimum temperuture of recombinant alpha-amylases is 50 ℃, can keep 65% above enzyme to live in 35-60 ℃ of scope, and 60 ℃ of enzyme work later on are with temperature rising decline (Fig. 4) rapidly.Tolerate 50min under 37 ℃ of conditions, enzyme work remains on more than 80%; Tolerate 10min under 60 ℃ of conditions, enzyme is lived loss rapidly to about 15%(Fig. 5).
<110〉Yunnan Normal University
<120〉a kind of from the grand genomic α-Dian Fenmei of animal excrement and gene thereof
<160> 2
<170> PatentIn version 3.5
<210> 1
<211> 1458
<212> DNA
<213〉the grand genome of animal excrement
<400> 1
gcgaccaatc gcgacagcta cgccgacacg ctgggtgacg ccaccttcga ggcggcgcgc 60
cagcggtacg gactgaccga ggatatgagt cacggcacga tcctgcatgc ctggatgtgg 120
tcgttcaaca cgatcaccgc caacatgaag gacatcgccg aggccggcta cacctcgatc 180
cagaccgagc cgatgagcca tatcaagacc aacacggcca acggcaagaa gttcaccgag 240
aactggtact acgtctacca gcccacctcc acctcgatcg gcaacttcgt ggtcggcacc 300
caggatgacc tcaagcgcat gtgcgccgag gcccataaat acggcatccg catcatcgtg 360
gacgtcgtgg ccaaccactt cacgtccgac tggaacgcca tcgactccag ctggaaggac 420
gccagcctgt tccacaagcg ctccaactgc tccggcgcca acggtgacaa catcaactac 480
ggcaaccgct ggcaggtgac ccagtgccac cttctcggcc tgtgggacat caacacccag 540
aaccagaccg cggcgaacaa gatgaaggag ttcctcgtgc aggccgtcaa cgacggtgtg 600
gacggcttcc gcttcgacgc cgccaagcat gtggagcttc cggacgagct gggcgagcat 660
tcggtctact gggacacgat cctggagaac ggcgcccagt accagtacgg cgaggtcctg 720
cagggagact ccggcctcga ctacagggcc tatgccaacc tcatgacgaa ccactcctcg 780
cgcggcggcg gcaacaccgc ctccgactac ggccgcaccg tgcgctcggc cgtcaagagc 840
cgcaacctct ccgcgggctc cctaagcaac atgagcaagg gcggcgtggc cgacgaccaa 900
ctggtcactt gggtcgagtc gcatgacaac tacgccaacg gcgacaagga atccacctac 960
ctgaccaacg atcagctgcg cttcggctgg gcccttgtgg cctcgcgctc cgcgggtgcg 1020
ccgctgtact tcaaccgccc ggtcggctcc ggcggaacca acccgcagtt cgccgaggtc 1080
agccagctcg gcgacgccgg tgacggcatg tggaaggaca aggccgtcgt ccaggtcaac 1140
aagttccaca acaagatgga cggcaacgcc gaatacctgc gcaactgccc gaacaacggc 1200
tcctgcctga tggtcgagcg ttacgccaag gatggccagt ccgccaacga cggcgtcgtg 1260
atcaccaaca tgggcggcga cacgagcctc gccggcaccg ccaccaccct ggatgacggc 1320
acctacaccg accaggtcaa cggcggcgcc atcaccgtct ccggcggcaa gatcacggcc 1380
ggcaccgcga agggcaacgc cgtaagcgcc tactactcac aggagaaggc cgaacaggtg 1440
gcctatgtga gactctag 1458
<210> 2
<211> 485
<212> PRT
<213〉the grand genome of animal excrement
<400> 2
Ala Thr Asn Arg Asp Ser Tyr Ala Asp Thr Leu Gly Asp Ala Thr Phe
1 5 10 15
Glu Ala Ala Arg Gln Arg Tyr Gly Leu Thr Glu Asp Met Ser His Gly
20 25 30
Thr Ile Leu His Ala Trp Met Trp Ser Phe Asn Thr Ile Thr Ala Asn
35 40 45
Met Lys Asp Ile Ala Glu Ala Gly Tyr Thr Ser Ile Gln Thr Glu Pro
50 55 60
Met Ser His Ile Lys Thr Asn Thr Ala Asn Gly Lys Lys Phe Thr Glu
65 70 75 80
Asn Trp Tyr Tyr Val Tyr Gln Pro Thr Ser Thr Ser Ile Gly Asn Phe
85 90 95
Val Val Gly Thr Gln Asp Asp Leu Lys Arg Met Cys Ala Glu Ala His
100 105 110
Lys Tyr Gly Ile Arg Ile Ile Val Asp Val Val Ala Asn His Phe Thr
115 120 125
Ser Asp Trp Asn Ala Ile Asp Ser Ser Trp Lys Asp Ala Ser Leu Phe
130 135 140
His Lys Arg Ser Asn Cys Ser Gly Ala Asn Gly Asp Asn Ile Asn Tyr
145 150 155 160
Gly Asn Arg Trp Gln Val Thr Gln Cys His Leu Leu Gly Leu Trp Asp
165 170 175
Ile Asn Thr Gln Asn Gln Thr Ala Ala Asn Lys Met Lys Glu Phe Leu
180 185 190
Val Gln Ala Val Asn Asp Gly Val Asp Gly Phe Arg Phe Asp Ala Ala
195 200 205
Lys His Val Glu Leu Pro Asp Glu Leu Gly Glu His Ser Val Tyr Trp
210 215 220
Asp Thr Ile Leu Glu Asn Gly Ala Gln Tyr Gln Tyr Gly Glu Val Leu
225 230 235 240
Gln Gly Asp Ser Gly Leu Asp Tyr Arg Ala Tyr Ala Asn Leu Met Thr
245 250 255
Asn His Ser Ser Arg Gly Gly Gly Asn Thr Ala Ser Asp Tyr Gly Arg
260 265 270
Thr Val Arg Ser Ala Val Lys Ser Arg Asn Leu Ser Ala Gly Ser Leu
275 280 285
Ser Asn Met Ser Lys Gly Gly Val Ala Asp Asp Gln Leu Val Thr Trp
290 295 300
Val Glu Ser His Asp Asn Tyr Ala Asn Gly Asp Lys Glu Ser Thr Tyr
305 310 315 320
Leu Thr Asn Asp Gln Leu Arg Phe Gly Trp Ala Leu Val Ala Ser Arg
325 330 335
Ser Ala Gly Ala Pro Leu Tyr Phe Asn Arg Pro Val Gly Ser Gly Gly
340 345 350
Thr Asn Pro Gln Phe Ala Glu Val Ser Gln Leu Gly Asp Ala Gly Asp
355 360 365
Gly Met Trp Lys Asp Lys Ala Val Val Gln Val Asn Lys Phe His Asn
370 375 380
Lys Met Asp Gly Asn Ala Glu Tyr Leu Arg Asn Cys Pro Asn Asn Gly
385 390 395 400
Ser Cys Leu Met Val Glu Arg Tyr Ala Lys Asp Gly Gln Ser Ala Asn
405 410 415
Asp Gly Val Val Ile Thr Asn Met Gly Gly Asp Thr Ser Leu Ala Gly
420 425 430
Thr Ala Thr Thr Leu Asp Asp Gly Thr Tyr Thr Asp Gln Val Asn Gly
435 440 445
Gly Ala Ile Thr Val Ser Gly Gly Lys Ile Thr Ala Gly Thr Ala Lys
450 455 460
Gly Asn Ala Val Ser Ala Tyr Tyr Ser Gln Glu Lys Ala Glu Gln Val
465 470 475 480
Ala Tyr Val Arg Leu
485

Claims (4)

1. one kind from the grand genomic alpha-amylase gene of animal excrement, it is characterized in that its nucleotide sequence is shown in SEQ ID NO.1.
2. one kind comprises the described recombinant expression vector from the grand genomic alpha-amylase gene of animal excrement of claim 1.
3. recombinant bacterial strain with the recombinant expression vector transformed host cell gained of the described alpha-amylase gene of claim 2.
4. one kind from the grand genomic α-Dian Fenmei of animal excrement, it is characterized in that its aminoacid sequence is shown in SEQ ID NO. 2.
CN201310249147.XA 2013-06-21 2013-06-21 Alpha-amylase derived from animal feces metagenome and gene of the alpha-amylase Expired - Fee Related CN103290039B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310249147.XA CN103290039B (en) 2013-06-21 2013-06-21 Alpha-amylase derived from animal feces metagenome and gene of the alpha-amylase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310249147.XA CN103290039B (en) 2013-06-21 2013-06-21 Alpha-amylase derived from animal feces metagenome and gene of the alpha-amylase

Publications (2)

Publication Number Publication Date
CN103290039A true CN103290039A (en) 2013-09-11
CN103290039B CN103290039B (en) 2014-12-31

Family

ID=49091569

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310249147.XA Expired - Fee Related CN103290039B (en) 2013-06-21 2013-06-21 Alpha-amylase derived from animal feces metagenome and gene of the alpha-amylase

Country Status (1)

Country Link
CN (1) CN103290039B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104250643A (en) * 2014-09-05 2014-12-31 中山大学 Amylase, and encoding gene and application thereof
CN113106082A (en) * 2021-05-27 2021-07-13 云南师范大学 Alanine racemase from animal manure metagenome as well as preparation and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LENA TASSE ET AL.: "Functional metagenomics to mine the human gut microbiome for dietary fiber catabolic enzymes", 《GENOME RESEARCH》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104250643A (en) * 2014-09-05 2014-12-31 中山大学 Amylase, and encoding gene and application thereof
CN113106082A (en) * 2021-05-27 2021-07-13 云南师范大学 Alanine racemase from animal manure metagenome as well as preparation and application thereof
CN113106082B (en) * 2021-05-27 2022-11-04 云南师范大学 Animal waste metagenome-derived alanine racemase and preparation and application thereof

Also Published As

Publication number Publication date
CN103290039B (en) 2014-12-31

Similar Documents

Publication Publication Date Title
CN101298604B (en) High-temperature acid-resistant alpha-amylase mutant strain and construction method thereof
CN105950592A (en) Salt-resistant ethanol-resistant trypsin-resistant xylosidase JB13GH39 and preparation method thereof
CN108715840B (en) A kind of low temperature exoinulinase mutant MutQ23 Δ 3 of heat resistance
Golotin et al. Optimization of cold-adapted alpha-galactosidase expression in Escherichia coli
CN103103206B (en) Alpha-amylase and gene of alpha-amylase, engineering bacteria containing gene and application of engineering bacteria
CN108707593A (en) A kind of low temperature exoinulinase mutant MutE137 Δs 5 and its application
CN104726434A (en) Xylanase XynRBM26 and encoding gene thereof
CN102220303A (en) Xylanase XynAHJ3 with protease resistance and gene thereof
CN101402964B (en) Alkali-fast high-activity alkalescent xylanase and encoding gene thereof
CN104726432B (en) A kind of D types β glucosides enzyme mutant and its expression plasmid and recombinant bacterium
CN109022396A (en) The alpha-amylase mutant and its application that a kind of enzyme activity improves
JP2015173602A (en) Method for obtaining natural variant of enzyme, and super thermostable cellobiohydrolase
CN103290039B (en) Alpha-amylase derived from animal feces metagenome and gene of the alpha-amylase
CN104877979B (en) A kind of its encoding gene of the β mannonases of first genomic source and its expression
CN103352031B (en) Glycosyltransferase gene and application thereof
CN108192903A (en) A kind of alkalescent xylanase and its encoding gene and application
CN102220304A (en) Low-temperature xylanase XynAHJ2 and gene thereof
CN107475222A (en) The heat-resisting human lysozyme of genetic engineering transformation
CN101701214B (en) Xylanase XYNA4 with wide pH applicability and gene and application thereof
JP2011205992A (en) β-GLUCOSIDASE INCREASING ACTIVITY IN PRESENCE OF GLUCOSE
CN104164441A (en) Three glufosinate-resistant rice cytoplasm type glutamine synthetase mutants
CN111748542B (en) Endo-xylanase mutant S07A11, and preparation method and application thereof
CN105087520B (en) A method of promoting recombinant extremely heat-resistant alpha-amylase solubility expression
CN111484988B (en) Bifunctional enzyme with xylanase and feruloyl esterase activities, and coding gene and application thereof
CN104278045B (en) A kind of alkali cellulose enzyme and DNA sequence thereof and application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141231

Termination date: 20160621